HilleVax, Inc. Quarterly Debt-to-equity in % from Q3 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: HilleVax, Inc. quarterly Debt-to-equity history and growth rate from Q3 2022 to Q3 2024.
HilleVax, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 29.4 %, a 23.8% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	29.4	+5.64	+23.8%	Sep 30, 2024
Q2 2024	29.2	+8.5	+41%	Jun 30, 2024
Q1 2024	28.4	+12	+72.9%	Mar 31, 2024
Q4 2023	26.6	-32.3	-54.8%	Dec 31, 2023
Q3 2023	23.7	-158	-86.9%	Sep 30, 2023
Q2 2023	20.7			Jun 30, 2023
Q1 2023	16.4			Mar 31, 2023
Q4 2022	58.9			Dec 31, 2022
Q3 2022	182			Sep 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.